Francesca Prestia

Dr. Francesca Prestia

University of Calabria, Department of Pharmacy and Health and Nutritional Sciences

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MNMarta Claudia Nocito
Marta Claudia Nocito
ALArianna De Luca
Arianna De Luca
FPFrancesca Prestia
Francesca Prestia
PAPaola Avena
Paola Avena
DPDavide La Padula
Davide La Padula
Vincenzo PezziVincenzo Pezzi
Vincenzo Pezzi
Curcumin, a main bioactive component of the Curcuma longa L. rhizome, is a phenolic compound that exerts a wide range of beneficial effects, acting as an antimicrobial, antioxidant, anti-inflammatory and anticancer agent. This review summarizes recent data on curcumin’s ability to interfere with the multiple cell signaling pathways involved in cell cycle regulation, apoptosis and the migration of several cancer cell types. However, although curcumin displays anticancer potential, its clinical application is limited by its low absorption, rapid metabolism and poor bioavailability. To overcome these limitations, several curcumin-based derivatives/analogues and different drug delivery approaches have been developed. Here, we also report the anticancer mechanisms and pharmacokinetic characteristics of some derivatives/analogues and the delivery systems used. These strategies, although encouraging, require additional in vivo studies to support curcumin clinical applications.